Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/209280
Title: | Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity |
Author: | Umeshappa, Channakeshava Sokke Solé, Patricia Yamanouchi, Jun Mohapatra, Saswat Surewaard, Bas G. J. Garnica Caparrós, Josep Singha, Santiswarup Mondal, Debajyoti Cortés Vicente, Elena D'Mello, Charlotte Mason, Andrew Kubes, Paul Serra, Pau Yang, Yang Santamaria, Pere |
Keywords: | Malalties autoimmunitàries Cèl·lules T Autoimmune diseases T cells |
Issue Date: | 7-Jun-2022 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | Invariant NKT (iNKT) cells comprise a heterogeneous group of non-circulating, tissue-resident T lymphocytes that recognize glycolipids, including alpha-galactosylceramide (?GalCer), in the context of CD1d, but whether peripheral iNKT cell subsets are terminally differentiated remains unclear. Here we show that mouse and human liver-resident ?GalCer/CD1d-binding iNKTs largely correspond to a novel Zbtb16+Tbx21+Gata3+MaflowRorc- subset that exhibits profound transcriptional, phenotypic and functional plasticity. Repetitive in vivo encounters of these liver iNKT (LiNKT) cells with intravenously delivered ?GalCer/CD1d-coated nanoparticles (NP) trigger their differentiation into immunoregulatory, IL-10+IL-21-producing Zbtb16highMafhighTbx21+Gata3+Rorc- cells, termed LiNKTR1, expressing a T regulatory type 1 (TR1)-like transcriptional signature. This response is LiNKT-specific, since neither lung nor splenic tissue-resident iNKT cells from ?GalCer/CD1d-NP-treated mice produce IL-10 or IL-21. Additionally, these LiNKTR1 cells suppress autoantigen presentation, and recognize CD1d expressed on conventional B cells to induce IL-10+IL-35-producing regulatory B (Breg) cells, leading to the suppression of liver and pancreas autoimmunity. Our results thus suggest that LiNKT cells are plastic for further functional diversification, with such plasticity potentially targetable for suppressing tissue-specific inflammatory phenomena.© 2022. The Author(s). |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41467-022-30759-w |
It is part of: | Nature Communications, 2022, vol. 13, num. 1 |
URI: | http://hdl.handle.net/2445/209280 |
Related resource: | https://doi.org/10.1038/s41467-022-30759-w |
ISSN: | 2041-1723 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic_NatureCommunications.pdf | 5.21 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License